Guidelines for the programmatic management of drug-resistant tuberculosis

All files are in PDF Format

Table of Contents

• Cover
• Acknowledgements, Abbreviations and acronyms, Preface
• Introduction
• Chapter 1 Background information on drug-resistant tuberculosis
• Chapter 2 Framework for effective control of drug-resistant tuberculosis
• Chapter 3 Political commitment and coordination
• Chapter 4 Definitions: case registration, bacteriology and treatment outcomes
• Chapter 5 Case-findings strategies
• Chapter 6 Laboratory aaspects
• Chapter 7 Treatment strategies for MDR-TB - Part 1 | Part 2
• Chapter 8 Mono- and poly-resistant strains (drug-resistant tuberculosis other than MDR-TB
• Chapter 9 Treatment of grug-resistant tuberculosis in special conditions and situations
• Chapter 10 HIV infection and MDR-TB
• Chapter 11 Initial evaluation, monitoring of treatment and management of adverse effects
• Chapter 12 Treatment delivery and adherence
• Chapter 13 Management of patients after MDR-TB treatment failure
• Chapter 14 Management of contacts of MDR-TB patients
• Chapter 15 Drug resistance and infection control
• Chapter 16 Human resources: training and staffing
• Chapter 17 Management of second-line antituberculosis drugs
• Chapter 18 Catergory IV recording and reporting system - Part 1 | Part 2
• Annex 1 Drug information sheets - Part 1 | Part 2
• Annex 2 Weight-based dosing of drugs for adults
• Annex 3 Suggestions for further reading
• Annex 4 List of complementary documents available on the WHO web site
• Annex 5 Drug groupings and abbreviations
• Forms